Cost-effectiveness of health-related lifestyle advice delivered by peer or lay advisors: Synthesis of evidence from a systematic review

Cost Effectiveness and Resource Allocation

Volumn 11, Issue 1, 2013, Pages

  Pennington, Mark ^a   Visram, Shelina ^b   Donaldson, Cam ^c   White, Martin ^d   Lhussier, Monique ^e   Deane, Katherine ^f   Forster, Natalie ^e   Carr, Susan M ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NORTHUMBRIA UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cost effectiveness; Health related lifestyle advisor; Peer counsellor

Indexed keywords

ARTICLE; BREAST FEEDING EDUCATION; COST; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIET; DRUG USE; EXERCISE; HEALTH BEHAVIOR; HEALTH CARE DISPARITY; HEALTH PROMOTION; HEALTH RELATED LIFESTYLE ADVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERVENTION STUDY; KNOWLEDGE; LIFESTYLE; LIFESTYLE MODIFICATION; MAMMOGRAPHY; MEDICAL RESEARCH; MENTAL HEALTH; MONEY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; QUALITY OF LIFE; RELAPSE; SMOKING CESSATION; SYSTEMATIC REVIEW; TELEPHONE; BREAST CANCER SCREENING; CANCER SCREENING; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; DIABETES CONTROL; DIET THERAPY; GENERAL CHRONIC DISEASE MANAGEMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEALTH IMPACT ASSESSMENT; HEALTH RELATED LIFESTYLE ADVISOR; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCREMENTAL COST EFFECTIVENESS RATIO; INFECTION PREVENTION; PEER COUNSELING; PSYCHOEDUCATION; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); TELEMEDICINE; UNLICENSED DRUG USE;

EID: 84888799063     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-11-30     Document Type: Article

References (91)

1. World Health Organization The World Health Report 2002 - Reducing risks, promoting healthy life 2002, Geneva: World Health Organization, World Health Organization.
2. Department of Health Tackling Health Inequalities: a programme for action 2003, London: Department of Health, Department of Health.
3. Liao Y, Tucker P, Okoro CA, Giles WH, Mokdad AH, Harris VB. Reach 2010 surveillance for health status in minority communities - United States, 2001-2001. MMWR Surveill Summ 2004, 53(6):1-36.
4. Buck D, Frosini F. Clustering of unhealthy behaviours over time. Implications for policy and practice 2012, London: King's Fund, Available at http://www.kingsfund.org.uk/publications/clustering-unhealthy-behaviours-over-time.
5. Department of Health Choosing health: making healthy choices easier 2004, London: The Stationery Office, Department of Health.
6. Kangas I. ''Lay' and 'expert': illness knowledge constructions in the sociology of health and illness'. Health 2002, 6(3):301-304.
7. Lorig K. Partnerships between expert patients and physicians. Lancet 2002, 359:814-815. 10.1016/S0140-6736(02)07959-X, 11897275.
8. Visram S, Drinkwater C. Health Trainers: a review of the evidence 2005, Newcastle-upon-Tyne: Northumbria University.
9. Visram S, Geddes L, Carr SM, Drinkwater C. An Evaluation of the Early Adopter Phase of the Health Trainers Project in the North East 2006, Newcastle-upon-Tyne: Northumbria University.
10. World Health Organization Strengthening the performance of community health workers in primary care: report of a WHO Study Group 1989, Geneva: WHO, World Health Organization.
11. Lewin SA, Dick P, Pond P, et al. Lay health workers in primary and community health care. Cochrane Database Syst Rev 2005, Issue 2: Art. no. CD004015.
12. Webel AR, Okonsky J, Trompeta J, Holzema WL. A systematic review of the effectiveness of peer-based interventions on health-related behaviours in adults. Am J Public Health 2010, 100:247-253. 10.2105/AJPH.2008.149419, 2804647,2804647, 20019321.
13. Viswanathan M, Kraschnewski J, Nishikawa B, Morgan LC, Thieda P, Honeycutt A, Lohr KN, Jonas D. Outcomes of Community Health Worker Interventions 2009, US: Agency for Healthcare Research and Quality, Evidence Reports/Technology Assessments, No. 181. Report No. 09-E014.
14. Buchan J, DalPoz M. 'Skill mix in the health care workforce: reviewing the evidence'. Bull World Health Org 2002, 80(7):575-580. 2567564, 12163922.
15. Carr SM, Lhussier M, Forster N, Geddes L, Deane K, Pennington M, Visram S, White M, Michie S, Donaldson C, Hildreth A. An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost effectiveness, equity and acceptability of different versions of health-related lifestyle adviser role in improving health. Health Technol Assess 2011, 15(9).
16. Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies 2003, Ontario, Canada: Public Health Research, Education and Development Program (PHRED), Effective Public Health Practice Project.
17. Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics 1996, 9:113-120. 10.2165/00019053-199609020-00003, 10160090.
18. Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals?. JAMA 2001, 286(23):2988-2992. 10.1001/jama.286.23.2988, 11743840.
19. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med 1989, 28:299-308. 10.1016/0277-9536(89)90030-0, 2649989.
20. Curtis L. Unit costs of health and social care 2008, Kent: Personal Social Services Research Unit.
21. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001, 74:579-584.
22. Orleans CT. Promoting the maintenance of health behavior change: recommendations for the next generation of research and practice. Health Psychol 2000, 19(1, suppl):76-83.
23. Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav 2008, 33:1516-1520. 10.1016/j.addbeh.2008.05.012, 2577779, 18706769.
24. Toobert DJ, Stryker LA, Barrera M, Glasgow RE. Seven-year follow-up of a multiple-health behavior diabetes intervention - HMC. Am J Health Behav 2010, 34(6):680-694. 3065935, 20604694.
25. Gilpin EA, Pierce JP, Farkas AJ. Duration of smoking abstinence and success in quitting. J Natl Cancer Inst 1997, 89(8):572-576. 10.1093/jnci/89.8.572, 9106646.
26. Kennedy A. The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health 2007, 61:254-261. 10.1136/jech.2006.053538, 2652924, 17325405.
27. Barlow JH, Turner AP, Wright CC. A randomized controlled study of the arthritis management programme in the UK. Health Educ Res 2000, 15:665-680. 10.1093/her/15.6.665, 11142075.
28. Griffiths C, Motlib J, Azad A, Ramsay J, Eldridge S, Feder G, et al. Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease. Br J Gen Pract 2005, 55:831-837. 1570787, 16281998.
29. Lorig KR, Ritter PL, Gonzalez VM. Hispanic chronic disease self management. Nursing Res 2003, 52:361-369.
30. Lorig KR, Sobel DS, Stewart AL, Brown BW, Bandhura A, Ritter P, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization. Med Care 1999, 37:5-14. 10.1097/00005650-199901000-00003, 10413387.
31. Richardson G, Kennedy A, Reeves D, Bower P, Lee V, Middleton E, et al. Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions. J Epidemiol Community Health 2002, 62:361-367.
32. Young RJ. Proactive call centre treatment support (PACCTS) to improve glucose control in type 2 diabetes. Diabetes Care 2005, 28:278-282. 10.2337/diacare.28.2.278, 15677779.
33. Gary TL. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med 2003, 37:23-32. 10.1016/S0091-7435(03)00040-9, 12799126.
34. Lujan J, Ostwald SK, Ortiz M. Promotora diabetes intervention for Mexican Americans. Diabetes Educ 2007, 33:660-670. 10.1177/0145721707304080, 17684167.
35. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
36. Mason LM, Young RJ, New JP, Gibson JM, Long AF, Gambling T, et al. Economic analysis of a telemedicine intervention to improve glycemic control in patients with diabetes mellitus: illustration of a novel analytic model. Dis Manage Health Outcomes 2006, 14:377-385.
37. Valentine WJ, Palmer AJ, Nicklasson L, Cobden D, Roze S. Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets. Int J Clin Pract 2006, 60:1138-1145. 10.1111/j.1742-1241.2006.01102.x, 16939559.
38. McEwan P, Peters JR, Bergenheim K, Currie CJ. Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster). Curr Med Res Opin 2006, 22:121-129. 10.1185/030079906X80350, 16393438.
39. Group CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 2002, 287:2542-2551. 10.1001/jama.287.19.2542, 12020335, Group CDC Diabetes Cost-effectiveness Group.
40. Bagust A, Hopkinson PK, Maier W, Currie CJ. An economic model of the long-term health care burden of type II diabetes. Diabetologia 2001, 44:2140-2155. 10.1007/s001250100023, 11793015.
41. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS no. 68). Diabetologia 2004, 47:1747-1759. 10.1007/s00125-004-1527-z, 15517152.
42. Brown JB, Russell A, Chan W, Pedula K, Aickin M. The global diabetes model: user friendly ersion 3.0. Diabetes Res Clin Pract 2000, 50(Suppl. 3):15-46.
43. May S, West R, Hajek P, McEwen A, McRobbie H. Randomised controlled trial of a social support ('buddy') intervention for smoking cessation. Patient Educ Couns 2006, 64:235-241. 10.1016/j.pec.2006.02.008, 16616450.
44. Emmons KM, Puelo E, Park E, Gritz ER, Butterfield RM, Weeks JC, et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol 2005, 23:6516-6523. 10.1200/JCO.2005.07.048, 16116148.
45. Woodruff SI. Evaluation of a culturally appropriate smoking cessation intervention for Latinos. Tob Control 2002, 11:361-367. 10.1136/tc.11.4.361, 1747696, 12432162.
46. West R, Edwards M, Hajek P. A randomized controlled trial of a 'buddy' system to improve success at giving up smoking in general practice. Addiction 1998, 93:1007-1011. 10.1046/j.1360-0443.1998.93710075.x, 9744131.
47. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996, 275:1247-1251. 10.1001/jama.1996.03530400035035, 8601956.
48. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997, 278:1759-1766. 10.1001/jama.1997.03550210057039, 9388153.
49. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 Years' observations on male British doctors. BMJ 2004, 328:1519-1528. 10.1136/bmj.38142.554479.AE, 437139, 15213107.
50. Rasmussen SR, Prescott E, Sorensen TIA, Sogaard J. The total lifetime health cost savings of smoking cessation to society. Eur J Public Health 2005, 15:601-606. 10.1093/eurpub/cki024, 16014659.
51. Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Engl J Med 1997, 337:1052-1057. 10.1056/NEJM199710093371506, 9321534.
52. West R. Getting serious about stopping smoking. A review of products, services and techniques 1997, London: No Smoking Day.
53. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002, 6(16).
54. Stapleton JA, Lowin A, Russell MA. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness. Lancet 1999, 354:210-215. 10.1016/S0140-6736(99)90001-6, 10421303.
55. Boyd KA, Briggs AH. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction 2009, 104:317-325. 10.1111/j.1360-0443.2008.02449.x, 19149829.
56. Andersen MR, Hager M, Su M, Urban N. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ Behav 2002, 29:755-770. 10.1177/109019802237942, 12456132.
57. Earp JA, Eng E, O'Malley MS, Altpeter M, Rauscher G, Mayne L, et al. Increasing use of mammography among older, rural African American women: results from a community trial. Am J Public Health 2002, 92:646-654. 10.2105/AJPH.92.4.646, 1447131, 11919066.
58. Paskett E, Tatum C, Rushing J, Michielutte R, Bell R, Foley KL, et al. Randomised trial of an intervention to improve mammography utilisation among a tri-racial rural population of women. J Nat Cancer Inst 2006, 98:1226-1237. 10.1093/jnci/djj333, 16954475.
59. Bird JA, McPhee SJ, Ha NT, Le B, Davis T, Jenkins CNH. Opening pathways to cancer screening for Vietnamese-American women: lay health workers hold a key. Prev Med 1998, 27:821-829. 10.1006/pmed.1998.0365, 9922064.
60. Rojnik K, Naversnik K, Mateovic-Rojnik T, Primiczakelj M. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. Value Health 2008, 11:139-148. 10.1111/j.1524-4733.2007.00223.x, 18380626.
61. Ahern CH, Shen Y. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines. Cancer Epidemiol Biomarkers Prev 2009, 18:718-725. 10.1158/1055-9965.EPI-08-0918, 2716399, 19258473.
62. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. [Erratum appears in Ann Intern Med 1998;128:878]. Ann Int Med 1997, 127:955-965. 10.7326/0003-4819-127-11-199712010-00001, 9412300.
63. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Nat Cancer Inst 2006, 98:774-782. 10.1093/jnci/djj210, 16757702.
64. Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, et al. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ 1998, 317:376-379. 10.1136/bmj.317.7155.376, 28630, 9694752.
65. Szeto KL, Devlin NJ. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy 1996, 38:101-115. 10.1016/0168-8510(96)00843-3, 10160378.
66. Dickson-Gomez J, Knowlton A, Latkin C. Hoppers and oldheads: qualitative evaluation of a volunteer AIDS outreach intervention. AIDS Behav 2003, 7:303-315. 10.1023/A:1025499904469, 14586192.
67. Dickson-Gomez J, Weeks M, Martinez M, et al. Times and places: process evaluation of a peer led HIV prevention intervention. Subst Use Misuse 2006, 41:669-690. 10.1080/10826080500411403, 16603454.
68. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol 2003, 22:332-339.
69. Weeks MR, Dickson-Gomez J, Mosack KE, Convey M, Martinez M, Clair S. The risk avoidance partnership: training active drug users as peer health advocates. J Drug Issues 2006, 36:541-570. 10.1177/002204260603600303, 2662598, 19337568.
70. Cohen DA, Wu SY, Farley TA. Comparing the cost-effectiveness of HIV prevention interventions. J Acquir Immune Defic Syndr 2004, 37:1404-1414. 10.1097/01.qai.0000123271.76723.96, 15483470.
71. Pinkerton SD, Abramson PR. The Bernoulli-process model of HIV transmission. Handbook of economic evaluation of HIV prevention programmes 1998, New York, NY: Plenum Press, Holtgrave DR.
72. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr 1990, 3:1010-1016. [Erratum appears in J Acquir Immune Defic Syndr 1991;4:450].
73. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992, 5:1116-1118.
74. Health Protection Agency (HPA) HIV in the United Kingdom: 2008 report 2008, London: Health Protection Agency, HIV and Sexually Transmitted Infections Department, Health Protection Agency (HPA).
75. Health Protection Agency (HPA) Unlinked Anonymous Prevalence Monitoring Programme: data to the end of 2007, IDUs survey 2008, London: Health Protection Agency Centre for Infections, Health Protection Agency (HPA).
76. Levy AR, James D, Johnston KM, Hogg RS, Harrigan PR, Harrigan BP, et al. The direct costs of HIV/AIDS care. Lancet Infect Dis 2006, 6:171-177. 10.1016/S1473-3099(06)70413-3, 16500598.
77. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, et al. Expanded screening for HIV in the United States: an analysis of cost-effectiveness. N Engl J Med 2005, 352:586-595. 10.1056/NEJMsa042088, 15703423.
78. Keyserling TC, Samuel-Hodge CD, Ammerman AS, Ainsworth BE, Henríquez-Roldán CF, et al. A randomized trial of an intervention to improve self-care behaviors of African-American women with type 2 diabetes: impact of physical activity. Diabetes Care 2002, 25:1576-1183. 10.2337/diacare.25.9.1576, 12196430.
79. Staten LK, Gregory-Mercado KY, Ranger-Moore J, Will JC, Giuliano AR, Ford ES, et al. Provider counselling, health education and community health workers: the Arizona WISEWOMAN project. J Women's Health 2004, 13:547-556.
80. Elder JP, Ayala GX, Campbell NR, Arredondo EM, Slymen DJ, Baquero B., et al. Long term effects of a communication intervention for Spanish-Dominant Latinas. Am J Prev Med 2006, 31:159-166. 10.1016/j.amepre.2006.04.001, 16829333.
81. Resnicow K, Campbell MK, Carr C, McCarty F, Wang T, Periasamy S, et al. Body and soul: a dietary intervention conducted through African American churches. Am J Prev Med 2004, 27:97-105. 10.1016/j.amepre.2004.04.009, 15261895.
82. Anand SS, Davis DA, Ahmed R, Jacobs R, Xie C, Hill A, et al. A family-based intervention to promote healthy lifestyles in an aboriginal community in Canada. Can J Public Health 2007, 98:447-452.
83. Dennis CL, Hodnett E, Gallop R, Chalmers B. The effect of peer support on breast-feeding duration among primiparous women: a randomised controlled trial. Canad Med Assoc J 2002, 166:21-28.
84. Morrow AL, Lourdes Guerrerro M, Shults J, Calva JJ, Lutter C, Bravo J, et al. Efficacy of home based peer counselling to promote exclusive breastfeeding: a randomised control trial. Lancet 1999, 353:1226-1231. 10.1016/S0140-6736(98)08037-4, 10217083.
85. Scientific Advisory Committee on Nutrition Infant Feeding Survey 2005: a commentary on infant feeding practices in the UK 2008, London: Scientific Advisory Committee on Nutrition, Scientific Advisory Committee on Nutrition.
86. Quinn PJ, O'Callaghan M, Williams GM, Najman JM, Andersen MJ, Bor W. The effect of breastfeeding on child development at 5 years: a cohort study. J Paediatr Child Health 2001, 37:465-469. 10.1046/j.1440-1754.2001.00702.x, 11885710.
87. Gillman MW, Rifas-Shiman SL, Camargo CA, Berkey CS, Frazier AL, Rockett HR, et al. Risk of overweight among adolescents who were breastfed as infants. JAMA 2001, 285:2461-2467. 10.1001/jama.285.19.2461, 11368698.
88. Sadauskaite-Kuehne V, Ludvigsson J, Padaiga Z, Jasinskiene E, Samuelsson U. Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. Diabetes Metabol Res Rev 2004, 20:150-157.
89. Ireys HT, Chernoff R, DeVet KA, Young K. Maternal outcomes of a randomised controlled trial of a community-based support program for families of children with chronic illnesses. Arch Pediatr Adolesc Med 2001, 155:771-777. 10.1001/archpedi.155.7.771, 11434842.
90. Okun A, Stein RE, Bauman LJ, Silver EJ. Content validity of the psychiatric symptom index, CES-depression scale, and state-trait anxiety inventory from the perspective of DSM-IV. Psychol Rep 1996, 79(3 Pt 1):1059-1069.
91. Pharaoh PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost-effectiveness of the NHS breast screening programme: life table model. BMJ 2013, 346:f2618. doi: 10.1136/bmj.f2618, 10.1136/bmj.f2618, 3649817, 23661112.